Connection

Mark Kindy to Drug Design

Back to Details
This is a "connection" page, showing publications Mark Kindy has written about Drug Design.
Mark Kindy
Connection Strength
0.341
Drug Design
  1. Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease. Biol Chem. 2010 Aug; 391(8):861-72.
    View in: PubMed
    Score: 0.341
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.